Baker McKenzie is continuing the expansion of its global M&A and Private Equity capabilities with the appointment of Jan Schubert (PICTURED) as a partner in its Frankfurt office, effective June 1, 2025. Schubert’s practice
Tags :Berthold Hummel
Baker McKenzie has advised ATB Therapeutics, a Belgian next-generation antibody company, on the successful closing of a 54 million euros Series A financing. With this financing, ATB Therapeutics will advance the development of oncology and immunology
